C

Celldex Therapeutics

Develops antibody-based therapies targeting inflammatory diseases

Senior Director - Medical Evidence Generation, Immunology

Biology & BiotechConfirmed live in the last 24 hours
Full-timeHampton, NJ, USA

About the Job

Requirements

  • An advanced scientific or healthcare degree, such as a PhD, PharmD, MD, MPH, MS, or equivalent, is required.
  • At least 10 years of pharmaceutical, biotechnology, clinical research, or Medical Affairs experience is required.
  • At least 5 years of experience supporting evidence generation, Medical Affairs research, HEOR, RWE, and/or integrated evidence planning initiatives is required.
  • Experience in immunology, allergy, inflammation, dermatology, or a related therapeutic area is required.
  • Strong expertise in evidence generation, Medical Affairs research, and clinical research, with working understanding of HEOR, RWE, and outcomes research in the pharmaceutical or biotechnology industry, is required.
  • A deep understanding of integrated evidence planning and evidence generation strategies supporting clinical and commercial objectives is required.
  • Strong scientific and clinical acumen, including the ability to interpret and communicate complex clinical and scientific data, is required.
  • Experience supporting or leading Medical Affairs Sponsored Studies, investigator-sponsored research, collaborative studies, and/or real-world evidence initiatives is required.
  • A strong understanding of clinical trial design, epidemiology, evidence methodologies, and scientific data interpretation is required.
  • The ability to lead complex cross-functional initiatives within a matrixed organization is required.
  • Strong strategic thinking, project leadership, and organizational skills are required.
  • Excellent written, verbal, and presentation communication skills are required.
  • The ability to build credibility and collaborative relationships with internal stakeholders, investigators, academic partners, and key opinion leaders is required.
  • Experience managing external vendors, budgets, timelines, and operational execution is required.
  • The ability to work effectively in a fast-paced, collaborative biotechnology environment is required.

Responsibilities

  • Lead the development and execution of integrated evidence generation strategies aligned with Medical Affairs & Evidence Generation, including HEOR, clinical development, and commercialization objectives.
  • Identify evidence gaps and develop strategic plans to generate clinical, real-world, health economics, and patient-centered evidence supporting Celldex products and pipeline programs.
  • Provide leadership and oversight for post-marketing Phase 3b/Phase 4 studies in collaboration with R&D, investigator-initiated research studies, collaborative research programs, and other evidence generation initiatives.
  • Partner with Medical Affairs & Evidence Generation, including HEOR, Clinical Development, Clinical Science, Biostatistics, Regulatory, Market Access, Commercial, and external experts to align evidence priorities and execution plans.
  • Drive the development and maintenance of integrated evidence plans across barzolvolimab and Celldex’s future immunology portfolio.
  • Collaborate with external investigators, academic institutions, cooperative groups, and key opinion leaders to advance strategic research initiatives.
  • Provide scientific and strategic input into study concept development, protocol design, evidence prioritization, and data generation strategies.
  • Support evidence generation across the product lifecycle, including late-stage development, launch readiness, post-launch evidence needs, and lifecycle management.
  • Translate scientific insights, clinical data, and external stakeholder feedback into actionable evidence strategies and recommendations for senior leadership.
  • Monitor scientific literature, competitive intelligence, treatment landscape trends, and evolving payer and access requirements in immunology, allergy, inflammation, and related therapeutic areas.
  • Ensure scientific rigor, operational excellence, and compliance with internal SOPs, FDA regulations, GCP guidelines, and applicable industry standards.
  • Partner with Scientific Communications and Publications to disseminate evidence through congresses, manuscripts, presentations, and scientific exchange initiatives.
  • Contribute to external scientific engagement, including advisory boards, congresses, investigator interactions, and scientific collaborations.
  • Manage external vendors, research partners, budgets, timelines, and operational execution as needed.
  • Support development of evidence generation infrastructure, processes, metrics, and operational best practices within Medical Affairs.

Desired Qualifications

  • Prior leadership experience within a matrixed pharmaceutical or biotechnology environment is preferred.
  • A strong understanding of trial design, biostatistics, and bioinformatics is highly desirable.
  • Experience supporting clinical-stage or commercial-stage products is preferred.
  • Experience interacting with investigators, academic institutions, cooperative groups, and external scientific collaborators is preferred.
  • Experience supporting global and U.S. evidence generation initiatives is preferred.

About the Company

Celldex Therapeutics

Develops antibody-based therapies targeting inflammatory diseases

Celldex Therapeutics develops antibody-based therapies for inflammatory, allergic, and autoimmune diseases, focusing on mast cell biology. Its lead program barzolvolimab is a humanized monoclonal antibody that inhibits KIT, reducing mast cell activity and inflammation; its pipeline includes other antibodies designed to engage the immune system or modulate disease pathways. The company leverages partnerships and licensing in addition to developing its own therapies to create a breadth of programs in its target areas. Its goal is to deliver therapies that lessen inflammation and autoimmune activity by targeting mast cells and related signaling pathways.

Company size
201-500
Company stage
IPO
Headquarters
Hampton, NJ
Founded
1983

Recently Posted Jobs

Explore more opportunities at Celldex Therapeutics

See more jobs